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Further phytochemical studies on the aerial parts of Phlomis viscosa (Lamiaceae) led to the isolation
of 24 compounds: 3 iridoid glycosides, 10 phenylethanoid glycosides, a megastigmane glycoside and
a hydroquinone glycoside, as well as 2 lignan glucosides and 7 neolignan glucosides, 1 of which is
new (17b). Compound 17b was obtained as a minor component of an inseparable mixture (2:1) of 2
neolignan glucosides (17a/b), and characterized as 30,4-O-dimethylcedrusin 9-O--glucopyranoside. Full
NMR data of the known 8-O-40 neolignan glucoside, erythro-1-(4-O--glucopyranosyl-3-methoxyphenyl)-
2-f2-methoxyl-4-[1-(E)-propene-3-ol]-phenoxylg-propane-1,3-diol (18) are also reported. All isolated
compounds were screened for cell growth inhibition versus 3 tumor cell lines (MCF7, NCI-H460, and
SF-268) and several phenylethanoid glycosides were found to possess weak antitumoral activity. The
phenylethanoid glycosides were also evaluated for their free radical (DPPH) scavenging, antibacterial
and antifungal activities. The free radical (DPPH) scavenging activities of verbascoside (4), isoacteoside
(5), forsythoside B (10), myricoside (13) and samioside (14) were found to be comparable to that of
dl --tocopherol. Compounds 4, 5, 10 and 14 (MIC: 500 g/mL) as well as Leucosceptoside A (8) and
13 (MIC:1000 g/mL) showed very weak activity against Gram (+) bacteria.
Key Words: Phlomis viscosa, iridoids, phenylethanoid glycosides, lignan glucosides, 8-O-40-oxylignan,
neolignan glucosides, biological activity.
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Introduction
In a previous study, we reported a nortriterpene and 2 oleanan-type triterpene glycosides from Phlomis
viscosa1. Further investigations into the chemistry of this plant resulted in the isolation of a variety of
glycosides of iridoid, phenylethanoid, megastigmane, neolignan and lignan types (Figure). The present
study reports the structural elucidation of the new compound, 30,4-O-dimethylcedrusin 9-O-glucopyranoside
(17b), as well as the complete NMR and other spectroscopic data for the known neolignan glucoside (18).
All isolated compounds were tested for their cell growth inhibition activities. Phenylethanoid glycosides
were also tested for their free radical scavenging and antimicrobial activities.
Experimental
General Experimental Procedures: Optical rotations were measured on a Rudolph autopol IV Po-
larimeter using a sodium lamp operating at 589 nm. UV spectra were recorded on a Shimadzu UV-160A
spectrophotometer. IR spectra (KBr) were measured on a Perkin Elmer 2000 FT-IR spectrometer. The
1D- and 2D-NMR spectra were obtained on a Bruker r© AMX 300 instrument (300.13 MHz for 1H and 75.47
MHz for 13C) and DRX 500 FT spectrometer (500.13 MHz for 1H and 125.77 MHz for 13C), at 295 K,
for all 1D- and 2D-NMR experiments. A Bruker with XWIN NMR software package was used to acquire
NMR data. Positive mode HR-MALDIMS were recorded on a Ionspec-Ultima-FTMS spectrometer with
2,5-dihydroxybenzoic acid (DHB) as matrix. TLC analyses were carried out on silica gel 60 F-254 precoated
plates (Merck, Darmstadt); detection by 1% vanillin/H2SO4. For medium-pressure liquid chromatographic
(MPLC) separations, a Bu¨chi 681 pump, a Bu¨chi 684 fraction collector, a Rheodyne injector, and Bu¨chi
glass columns (column dimensions 2.6 x 46 cm, and 1.8 x 35 cm) were used. Silica gel 60 (0.063-0.200 mm;
Merck, Germany) was utilized for open column chromatography (CC) and vacuum liquid chromatography
(VLC). LiChroprep C-18 (Merck) material was used for MPLC and VLC. Sephadex LH-20 (Fluka) was also
used for further separations.
Plant Material: Phlomis viscosa Poiret was collected from Osmaniye, Du¨zici (Haruniye), above
C itli Village (Turkey) on July 1, 2001. The plant specimen was identied by Dr. Ali A. Do¨nmez. The
voucher specimen (AAD 9493) has been deposited at the Herbarium of the Department of Biology, Faculty
of Science, Hacettepe University, Ankara, Turkey.
Extraction and Isolation: The powdered herb of P. viscosa (350 g) was extracted with EtOH (90,
2 x 2.5 L, 5 h) and then ltered. The ltrates were combined and evaporated to dryness in vacuo to yield
65 g crude extract (yield 18.7%). The EtOH extract was suspended in H2O (100 mL), and then extracted 3
times with CHCl3 (100 mL x 3). The remaining water phase yielded 41.9 g crude extract upon concentration.
An aliquot of the water extract (39.9 g) was mounted on a column packed with polyamide (200 g). Elution
with increasing amounts of MeOH in H2O (0-100%; H2O 1250 mL, with increasing 20% MeOH, each 500
mL, and 1000 mL MeOH) yielded 42 fractions (each 100 mL), which were combined into 13 fractions (frs.
A-M). Fr. A (4.5 g) was subjected to C18-MPLC (column dimensions: 2.6 x 46 cm), eluted with H2O (500
mL), MeOH-H2O mixtures (5-50% MeOH, with increasing 10% MeOH, each 200 mL) and MeOH (300 mL)
to yield 5 major fractions, A1-A5. Fraction A2 yielded pure lamiide (2, 1794 mg). Fraction A4 (120 mg) was
rechromatographed over a SiO2 (12 g) column (CH2Cl2-MeOH-H2O, 90:10:1, 200 mL) to give 1 (23 mg) and
15 (3.5 mg). Fr. B (6.0 g) was rich in 2. Fr. C (1.834 g) was chromatographed over C18-MPLC (column
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dimensions: 2.6 x 46 cm) employing a MeOH-H2O gradient (10-30% with increasing 5%; each 200 mL) to
yield 6 (39 mg). Fr. D (926 mg) was similarly subjected to C18-MPLC (column dimensions: 3 x 24 cm)
employing MeOH-H2O gradient (25-80% with increasing 2.5-5%; each 100 mL) to yield 8 major fractions,
D1-D8. Repeated chromatography of fr. D2 (62 mg) on a SiO2 (35 g) column (EtOAc-MeOH-H2O, 100:10:5,
200 mL) yielded 18 (9 mg). Fr. D7 (67 mg) was applied to a (15 g) column packed with SiO2 using CH2Cl2-
MeOH-H2O (90:10:1, 300 mL, and 80:20:2, 200 mL) to obtain 23 (8 mg). Fr. E (214 mg) was subjected to a
SiO2 CC (35 g) employing a EtOAc-MeOH-H2O mixture (100:10:5, 600 mL) to aord 3 (28 mg) and 20 (18
mg). Fr. F (848 mg) was likewise subjected to a SiO2 (100 g) CC utilizing CH2Cl2-MeOH-H2O mixtures
(80:20:2 and 80:20:1, both 300 mL) to yield 4 fractions, F1−4. Fr. F3 (390 mg) was subjected to C18-MPLC
(column dimensions: 3 x 24 cm) using stepwise gradients of MeOH in H2O (25-50% with increasing 5%; each
200 mL) to yield 16 (8.5 mg), 22 (8 mg), a mixture 21a and b (17 mg), 3 (153 mg) and a mixture of 17a and
b (18 mg). Fr. G (424 mg) was also applied to a SiO2 (40 g) CC employing CH2Cl2-MeOH-H2O mixtures
(90:10:0.5 to 61:32:7, totally 1200 mL) to aord 19 (11 mg), 12 (20 mg) and 11 (34 mg). Purication of fr.
H (435 mg) by SiO2 (40 g) CC using EtOAc-MeOH-H2O (100:10:5, 500 mL) furnished 10 (103 mg). Fr. I
(763 mg) was subjected to C18-MPLC (column dimensions: 3 x 24 cm) employing a MeOH-H2O gradient
(20-40% with increasing 2.5%; each 200 mL) to yield 9 (48 mg), a crude fraction of 13 (237 mg), 10 (106
mg) and norviscoside (16 mg) [1]. The fraction containing myricoside (13) was applied to a SiO2 (35 g)
column using EtOAc-MeOH-H2O (100:15:5 to 100: 15:10, totally 300 mL) to obtain 10 (7 mg) and 13 (66
mg). Fr. J (2737 mg) was likewise subjected to C18-MPLC (column dimensions: 2.6 x 46 cm) using stepwise
gradients of MeOH in H2O (20-100% with increasing 5%; each 200 mL) to yield 4 (1380 mg) and 8 (63
mg), in addition to crude 7 (143 mg) and 2 triterpenic glycosides1. The fraction containing compound 7
was further puried over a SiO2 (12 g) column eluting with CH2Cl2-MeOH-H2O mixtures (90:10:1, 80:20:2
and 70:30:3, each 100 mL) to aord pure 7 (29 mg). Fr. K (3800 mg) was subjected to C18-MPLC (column
dimensions: 2.6 x 46 cm) using stepwise gradients of MeOH in H2O (25-100% with increasing 5%; each 200
mL) to yield 4 (1634 mg) and 5 (557 mg) in addition to fractions rich in flavonoid glycosides (fr. K3; PV-37,
PV-38), and triterpenes (fr. K3 and fr. K4). Fr. L (2145 mg) was rich in chlorogenic acid.
30,4-O-dimethylcedrusin 90-O--glucopyranoside and 30,4-O-dimethylcedrusin 9-O--glu-
copyranoside (17a/17b): ESI-MS: m=z 559 [M + Na]+ (C27H36O11). 1H-NMR (CD3OD, 500 MHz) and
13C-NMR (CD3OD, 75 MHz): see Table 1.
Erythro-1-(4-O--glucopyranosyl-3-methoxyphenyl)-2-f2-methoxyl-4-[1-(E)-propene-3-ol]-
phenoxylg-propane-1,3-diol (18): Amorphous powder; []25D : - 12.0 (c 0.1, MeOH). CD (EtOH, c 0.13
gl−1; 2.24 x 10−4 M): []214 {2500, []226 {4600,[]235 {1700, []250 {100. IR (KBr): max 3395 (OH), 1502,
1450 (arom.), 1066, 1024 cm−1 (C-O-C). UV (MeOH): max 215, 268, 299 sh, 324 nm. HR-MALDI-MS:
m=z 561.1950 [M + Na]+ (calcd. for C27H34O13Na, 561.1943). 1H-NMR (CD3OD, 500 MHz) and 13C-NMR
(CD3OD, 75 MHz): see Table 2.
Cytotoxicity Assay: Compounds were dissolved in DMSO to yield a nal test solution with 0.25%
DMSO. For both the 3-cell prescreen2 and 60-cell screen3 , compounds were dissolved in DMSO at 40 mM to
achieve a nal concentration of 100 M in the assay. Five doses were titrated from this high concentration in
the 60-cell tests. The endpoint was read at 48 h in both cases; for the prescreen, the endpoint was determined
by Alamar blue, while in the 60-cell assay the endpoint was checked using sulforhodamine B staining.
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Table 1. 13C- and 1H-NMR spectroscopic data of compounds 17a and 17b (CD3OD, C : 75 MHz, H : 500 MHz).
17a 17b
C/H DEPT C H HMBCa C H HMBCa
1 C 136.91 - H-2, H-2, H-8 136.91 - H-7
2 CH 110.61 6.98 d H-7 110.79 7.03 d H-7
(1.8) (1.8)
3 C 150.53 - H-2, H-5, 3-OMe 150.40 - 3-OMe
4 C 150.22 - 4-O-Me 150.20 - 4-O-Me
5 CH 112.79 6.91 d 112.75 6.90 d
(8.3) (8.3)
6 CH 119.41 6.74 dd H-7 119.41 6.97 dd H-7
(8.3, 1.8) (8.3, 1.8)
7 CH 88.70 5.52 d H-2, H-6 88.70 5.64 d
(6.2) (6.0)
8 CH 55.53 3.46 dt H2-9, H-7, H-60 53.38 3.63 m H-7
(6.2, 7.3)
9 CH2 65.02 3.85b 72.50 3.75b H-100
3.76 dd
(11.1, 7.3)
3-OMe CH3 56.46 3.79 s 56.46 3.80 s
4-OMe CH3 56.41 3.81 s 56.41 3.82 s
10 C 137.10 - H-70 137.02 - H2-70
20 CH 114.17 6.76 br s H-60, H2-70 114.12 6.73 br s H2-70
30 C 145.20 - H-20, 30-OMe 145.50 - H-20, 3-OMe
40 C 147.46 - H-20, H-60 145.46 -
50 C 129.65 - H-7, H-8, H2-9 129.40 - H-7
60 CH 118.07 6.75 br s H-20, H2-70 118.16 6.78 br s
70 CH2 32.90 2.68 t H-20, H-60, H2-90 32.90 2.62 t
(7.4) (7.4)
80 CH2 32.89 1.91 tt H2-90 35.83 1.81 tt H2-70, H2-90
(7.4, 6.5) (7.4, 6.5)
90 CH2 68.89 3.92 dt H-100, H2-70 62.20 3.56 t
(10.2, 6.5) (6.5)
3.51 dt
(10.2, 6.5)
30-OMe CH3 56.75 56.75
100 CH 104.56 4.25 d H-200 104.60 4.36 d
(7.8) (7.8)
200 CH 75.17 3.20 dd 75.17 3.22 dd
(7.8, 9.0) (7.8, 9.0)
300 CH 78.12 3.36 t 78.26 3.36 t
(9.0) (9.0)
400 CH 71.64 3.30 t 71.64 3.30 t
500 CH 77.91 3.26 ddd 78.07 3.26 ddd
(9.0, 5.0, 2.0) (9.0, 5.0, 2.0)
600 CH2 62.75 3.88b 62.21 3.88b
3.66 dd 3.66
(12.5, 6.0) (12.5, 6.0)
a From C to H.
b Overlapped.
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Table 2. 13C- and 1H-NMR spectroscopic data of 18 (CD3OD, C : 75 MHz, H : 500 MHz).
18
C/H DEPT C H HMBCa
1 C 137.4 - H-2, H-6, H-7, H-8
2 CH 112.4 7.13 d (2.1) H-6, H-7
3 C 150.5 - H-2, H-5, 3-OMe
4 C 147.4 - H-100, H-2, H-5, H-6
5 CH 117.6 7.11 d (8.6)
6 CH 120.6 6.96 dd (8.6, 2.1) H-2, H-7
7 CH 73.6 4.94 d (5.1) H-2, H-6, H-8
8 CH 86.5 4.33 m H2-9, H-7
9 CH2 62.2 3.77 dd (12.0, 6.4) H-7, H-8
3.49 dd (12.0, 6.0)
3-OMe CH3 56.5 3.82 s
10 C 133.1 - H-20, H-60, H-70, H-80
20 CH 111.2 7.04 d (2.0) H-60
30 C 151.7 - 30-OMe
40 C 149.1 - H-8, H-20, H-50, H-60
50 CH 118.5 6.96 d (8.0)
60 CH 120.7 6.90 dd (2.0, 8.0) H-20, H-70
70 CH 131.4 6.52 d (15.8) H-20, H-60, H-80, H2-90
80 CH 128.6 6.26 dt (15.8, 6.5) H2-90
90 CH2 63.8 4.20 d (6.5) H-70, H-80
30-OMe CH3 56.6 3.84 s
100 CH 102.9 4.81 d (7.8) H-200
200 CH 74.9 3.47b
300 CH 78.2 3.40b
400 CH 71.3 3.41b
500 CH 77.8 3.48b
600 CH2 62.5 3.88b,
3.69 dd (12.0, 5.0)
a From C to H.
b Overlapped.
Measurement of DPPH Radical-Scavenging Activity: MeOH solutions of the compounds
at various concentrations were added to 1.5 x 10−5 M DPPH (2,2-diphenyl-1-picrylhydrazil) in MeOH.
Absorbance at 520 nm was determined after 30 min of incubation at room temperature. The radical
scavenging activity was determined by comparing the absorbance with that of a blank (100%) containing
only DPPH and solvent. dl --tocopherol was used as standard, and samples were prepared using the same
dilution procedures4 .
Antimicrobial Activity Studies: Minimum inhibitory concentrations (MICs) were determined by
broth microdilution following the procedures recommended by the National Committee for Clinical Labo-
ratory Standards5. Two Gram-positive and two Gram-negative bacteria were used (Staphylococcus aureus
ATCC 29213, Enterococcus faecalis 29212, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa
ATCC 27853). Antifungal activities of the compounds were tested towards 3 yeast-like fungi: Candida al-
bicans ATCC 90028, C. krusei ATCC 6258 and C. parapsilosis ATCC 22019. Mueller-Hinton broth (Difco
Laboratories, Detroit, MI, USA) was used for testing the bacterial strains. For Candida species, RPMI-1640
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medium with L-glutamin, buered with 3-(N-Morpholino) Propanesulfonic acid (MOPS) (ICN, FLOW; Au-
rora, OH, USA) was used. The inoculum densities were 5 x 105 colony forming units per milliliter (cfu/mL)
and 0.5{2.5 x 103 cfu/mL for bacteria and fungi, respectively. The compounds tested were dissolved in
distilled water, except for 4 (7, 8, 11, 12) of them, which were rst solubilized in a minimal amount of
dimethylsulfoxide and the rest of the volume was adjusted with distilled water for the required concentra-
tion. The nal 2-fold concentrations were prepared from 1000 to 0.98 g/mL in microtiter plates. Ampicillin
and fluconazole were used as references. Two-fold dilutions were used for both of them from 64 to 0.0625
g/mL. Microtiter plates were incubated for 18-24 h at 35 C for testing the bacterial strains. For yeast-
like fungi, MICs were determined after incubation for 48 h at 35 C. Minimum inhibitory concentrations
were dened as the lowest concentration of the antimicrobial agents that inhibited visible growth of the
microorganism.
Results and Discussion
Compounds 17a and 17b were obtained as an inseparable (2:1) mixture. The positive ion ESIMS of
this mixture exhibited a single pseudomolecular ion [M + Na]+ at m=z 559 and [M + K]+ at m=z 575
compatible with the molecular formula C27H36O11 for both. Although most of the NMR signals appeared
double, indicating a close structural similarity between 17a and 17b, DQF-COSY, HSQC and HMBC
experiments enabled distinct assignments for the individual components of the mixture. 1H- and 13C-NMR
data (Table 1) assigned for the major compound of the mixture (17a) were identical with those reported for
(-)-30,4-O-dimethylcedrusin 90-O--glucopyranoside (= 4-O-methyldihydrodehydrodiconiferyl alcohol 90-O-
-glucopyranoside), previously reported from Phlomis chimerae6. The NMR resonances observed for H-7,
H-8, H2-9, H-70, H-80 and H2-90 and C-8, C-9, C-80 and C-90 atoms of 17b (Table 1) indicated that the only
dierence between 17a and 17b stems from the site of glycosidations. The slight (+ 0.11) downeld shifting
of the anomeric proton of glucose (H-100, H 4.36 d, J = 7.8 Hz), as well as a prominent long range correlation
between this proton (H-100) and the oxymethylene carbon (C-9, C 72.50) of the benzofuran moiety, suggested
that the glucose unit was attached at C-9, and not at C-90. Based on these results, the structure of the
minor constituent of the mixture (17b) was determined as 30,4-O-dimethylcedrusin 9-O--glucopyranoside.
A survey showed 17b was a new compound to the literature.
Compound 18 was obtained as an amorphous powder ([]D = {12). Its molecular formula (C26H34O12)
was determined by positive-ion HR-MALDIMS ([M + Na]+m=z 561.1950, calcd. for C26H34O12Na, 561.1943)
and 13C NMR data (Table 2). The 1H-NMR spectrum displayed 2 sets of signals due to 1,3,4-trisubstituted
aromatic rings, 2 oxymethines, 2 oxymethylenes and 2 trans-oriented olenic protons together with an
anomeric proton and two methoxyl signals. The 13C NMR spectrum exhibited 26 signals, 6 of which were
ascribed to a hexose unit. The complete assignments of all proton and carbon resonances were based on the
DQF-COSY, HSQC, HSQC-TOCSY and HMBC experiments. The anomeric proton resonance appeared at
H 4.81 (d, J = 7.8 Hz, H-100) and the corresponding carbon resonance (C 102.9) along with the other sugar
signals indicated the presence of a -glucopyranose unit in 18. The doublet signal at H 4.94 (J = 5.1 Hz,
H-7) was coupled to the multiplet at H 4.33 (H-8), which, in turn, was coupled to 2 double doublets at H
3.77 (J = 12.0 and 6.4 Hz, H-9a) and H 3.49 (J = 12.0 and 6.0 Hz, H-9b), thus suggesting a chain of 3
carbons, all bearing oxygen (C-7, C-8 and C-9, respectively). The 2 trans-oriented olenic protons (H 6.26
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dt, J = 15.8, 6.5 Hz, 6.52 d, J = 15.8 Hz) and the second oxymethylene protons (H 4.20 d, J = 6.5 Hz) were
observed in the same spin system, and were assigned to an (E)-coniferyl alcohol side chain. The HMBC
spectrum (Table 2) revealed the connectivities between the molecular fragments exhibiting long-range cor-
relations from the quaternary carbon resonance at C 147.4, assigned as C-4, to the anomeric proton of
the glucose unit, and the protons assigned to H-2, H-5 and H-6 of one of the 1,3,4-trisubstituted aromatic
rings. The long-range correlations from C-40 (C 149.1) to H-20, H-50 and H-60 of the second aromatic ring,
as well as to H-8, suggested the presence of an 8-O-40-neolignan structure. Furthermore, HMBC correla-
tions from C-1 to H-2, H-6, H-7 and H-8, as well as from C-10 to H-20, H-60, H-70 and H-80, established
the remaining connectivities. Finally, the long-range correlations from C-3 to 3-OMe and C-30 to 30-OMe
allowed the locations of 2 methoxyl groups on the aromatic rings. These results showed that 18 has the
same constitution as reported for an 8-O-40 neolignan glucoside isolated from Arum italicum (established
as its peracetylated derivative)7. Moreover, the small coupling constant (J7;8 = 5.1 Hz) of the benzylic
proton (H-7), and the chemical shifts of H-7 and H-8, as well as those of C-7 (C 73.6) and C-8 (C 86.5),
agreed with an erythro-conguration8. Based on the above evidence, and due to the almost superimposable
CD-spectrum with that of the derivative7 (see Experimental), the structure of 18 was considered to be
(7S,8R)-8-O-40 neolignan 4-O--glucopyranoside f= erythro-1-(4-O--glucopyranosyl-3-methoxyphenyl)-2-
f2-methoxyl-4-[1-(E)-propene-3-ol]-phenoxylg-propane-1,3-diolg.
In addition to these compounds, 3 known iridoid glycosides [ipolamiide (1)9, lamiide (2)9 and lami-
idoside (3)10], 10 known phenylethanoid glycosides [verbascoside (4)11, isoacteoside (5)12, decaeoylver-
bascoside (6)12, martynoside (7)13, leucosceptoside A (8)14, -hydroxyverbascoside (9)15, forsythoside B
(10)16, alyssonoside (11)17, leucosceptoside B (12)15 and myricoside (13)18] a known megastigmane gly-
coside [phlomuroside (15)19], a known hydroquinone glycoside [seguinoside K20], 4 known neolignan glu-
cosides [dehydrodiconiferylalcohol 90-O--glucopyranoside (19)21, dihydrodehydrodiconiferylalcohol 4-O--
glucopyranoside (20)22, a mixture of dihydrodehydrodiconiferylalcohol 9-O--glucopyranoside and dihy-
drodehydrodiconiferylalcohol 90-O--glucopyranoside (21a/21b)22] and 2 lignan glucosides [lariciresinol 4-
O--glucopyranoside (22)23, and syringaresinol 40-O--glucopyranoside (23)24] were also isolated and iden-
tied by comparison of their spectroscopic (NMR and MS) data and optical rotation values with those
published in the literature.
Samioside (14) has been isolated from P. samia as reported in a previous study25. Due to its structural
similarity to compounds 4-13, samioside was also evaluated for its biological activities.
All compounds including samioside (14) were tested for cell growth inhibition versus 3 tumor cell lines
(MCF7, NCI-H460, and SF-268) in the US National Cancer Institute cancer prescreen at a single dose of
100 M3. None of the iridoid glycosides were active in the prescreen. The other 6 phenylethanoid glycosides
(4, 5, 10, 12, 13, 14) tested reduced the growth of at least 1 cell line to <32% of the control, and were
tested further against the full 60-cell line panel3. The phenylpropanoid glycosides acteoside (4), isoacteoside
(5), forsythoside B (10), alyssonoside (11), myricoside (13) and samioside (14) were tested against the full
panel; however, the concentrations required to inhibit cell growth at the GI-50 level were greater than 47
M in all cases, with minimal dierential inhibition among the cell lines. Thus, these compounds were not
investigated further as inhibitors of cancer cell growth.
The DPPH radical scavenging activities of phenylethanoid glycosides are summarized in Table 3. The
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results conrmed that the respective activities of compounds 4, 5, 10, 13 and 14 were comparable to that
of dl --tocopherol, while the other compounds showed moderate activities. These results suggested that the
antioxidative eect of these compounds might be potentiated by an increase in the number of free phenolic
hydroxyl groups in the molecule.
Table 3. Free radical (DPPH) scavenging activity of compounds 4-14.
Compounds 10 (M) 25 (M) 50 (M) 100 (M) 200 (M) IC50 (M)
(4) Verbascoside 40.83 45.39 54.96 92.36 97.53 75.5
(5) Isoacteoside 16.33 25.93 57.82 93.89 94.52 225.4
(6) Decaeoylacteoside - - 10.7 14.2 46.0 355.3
(7) Martynoside - - 7.6 15.7 26.4 87.0
(8) Leucosceptoside A 4.2 16.4 26.7 58.0 80.7 125.4
(9) -hydroxyacteoside - 11.8 51.7 46.8 66.0 52.1
(10) Forsythoside B 7.6 38.8 44.3 89.6 92.2 137.1
(11) Alyssonoside - 5.0 12.2 27.6 79.7 131.2
(12) Leucosceptoside B 15.0 16.8 24.2 38.2 72.5 61.3
(13) Myricoside 17.4 24.8 42.8 75.6 81.4 46.8
(14) Samioside 18.5 34.0 59.4 86.6 94.7 115.0
dl --tocopherol 2.3 13.1 25.4 32.6 92.00 75.5
Phenylethanoid glycosides (4-14) were tested for their antibacterial and antifungal activities. Com-
pounds 4, 5, 10 and 14 (MIC: 500 g/mL) as well as 8 and 13 (MIC:1000 g/mL) showed very weak
activity against Gram (+) bacteria. All compounds were inactive towards Gram (-) bacteria and C. albicans
(MICs > 1000 g/mL). Isoverbascoside (5) exhibited slight antifungal potential against 2 yeast-like fungi
(MIC: 1000 g/mL), while samioside (14) weakly inhibited the growth of C. krusei (MIC: 1000 g/mL).
As part of our continuing project to identify the secondary metabolites of Phlomis species growing
in Turkey, we have studied all 33 species of this genus. Among them, P. viscosa had the richest chemical
diversity, especially for its lignan and phenylethanoid glycoside content.
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